SARA RANDALL-MACDONNELL: Open Payments
NPI 1225293764 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,364 in 103 payments from 21 companies in 2025. Trend: 2023 $2,117 · 2024 $2,481 · 2025 $2,364
Food & beverage: $2,364
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $413 |
| Novo Nordisk Inc | 14 | $314 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $230 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $202 |
| PFIZER INC. | 9 | $155 |
| AstraZeneca Pharmaceuticals LP | 8 | $148 |
| Amgen Inc. | 9 | $148 |
| E.R. Squibb & Sons, L.L.C. | 1 | $123 |
| Lilly USA, LLC | 2 | $117 |
| Otsuka America Pharmaceutical, Inc. | 1 | $108 |
Products named: VRAYLAR, CAPLYTA, Wegovy, NURTEC ODT, REXULTI, Ozempic, EVENITY, COBENFY.
Industry payments across FL — which companies pay providers there.
